GSK president, global pharma Abbas Hussain to leave
Mr. Hussain joined GSK in 2008 and has held roles of increasing responsibility within the company’s pharmaceutical business. He is a member of GSK’s executive team and a board member of ViiV Healthcare.
Previously he was President, Europe at Eli Lilly and before that Vice President, Europe with specific responsibility for the Western European Mid-Size countries, Africa & Middle East Area/Commonwealth of Independent States and Central & Eastern Europe regions.
Mr. Hussain joined Lilly UK in 1988 as Sales Representative GP & Hospital Sales East London.
He then moved to Australia in 1990, where he became Associate of Market Research & New Product Planning and subsequently District Sales Manager.
In 1994, he moved to Indianapolis as Associate of Global Product Planning (Cardiovascular Business Unit), becoming Associate of Business Development Asia Pacific the following year.
He took on the role of Pharmaceutical Sales & Marketing Director in India in 1996, and Managing Director of Turkey in 1998.
Mr. Hussain moved to Germany in 2001 as General Manager, Lilly Deutschland as well as General Manager and Speaker, Lilly Pharma Holding GmbH. He was appointed European Mid-Size Area Director in 2003.
He was appointed to the ViiV Healthcare Ltd. Board in October 2009.
Mr. Hussain has a degree in Medicinal Chemistry & Pharmacology from Loughborough University in the UK. ■
LATEST MOVES FROM United Kingdom
- Mylan appoints Daniel M. Gallagher as chief legal officer
- Bunzl appoints Stephan Nanninga as director
- PowerHouse appoints Christopher Vanezis as CFO
- CML Microsystems appoints Geoff Barnes as director
- Concepta appoints Neil Mesher as director
More inside POST
RWE yearly net loss $6.02 billion Earnings